Types of Masses |
Male |
Female |
Male : female Ratio |
Total |
Non Neoplastic |
25 |
20 |
1.25 : 1 |
45 |
Neoplastic Benign |
07 |
03 |
2.33 : 1 |
10 |
Neoplastic Malignant |
05 |
02 |
2.5 : 1 |
07 |
Total |
37 |
25 |
1.48 : 1 |
62 |
Age(Years) |
Non neoplastic |
Neoplastic Benign |
Neoplastic Malignant |
Total |
||||
Male |
Female |
Male |
Female |
Male |
Female |
Male |
Female |
|
0-10 |
02 |
00 |
00 |
00 |
00 |
00 |
02 |
00 |
11-20 |
05 |
09 |
01 |
01 |
00 |
00 |
06 |
10 |
21-30 |
04 |
02 |
01 |
01 |
01 |
01 |
06 |
04 |
31-40 |
06 |
05 |
03 |
00 |
00 |
00 |
09 |
05 |
41-50 |
06 |
03 |
02 |
01 |
02 |
00 |
10 |
04 |
51-60 |
01 |
01 |
00 |
00 |
02 |
00 |
03 |
01 |
61-70 |
01 |
00 |
00 |
00 |
00 |
00 |
01 |
00 |
71-80 |
00 |
00 |
00 |
00 |
00 |
01 |
00 |
01 |
Total |
25 |
20 |
07 |
03 |
05 |
02 |
37 |
25 |
Types of Lesion |
Histopathological Findings |
Number of Cases(% by Type of lesion) |
Number of Cases(% of Total) |
Non Neoplastic |
Inflammatory Nasal Polyp |
28(62.2) |
28(45.16) |
Allergic Polyp |
05(11.1) |
05(8.06) |
|
Granulomatous Lesion |
03(6.66) |
03(4.83) |
|
Tuberculosis |
02(4.44) |
02(3.22) |
|
Mucormycosis |
02(4.44) |
02(3.22) |
|
Rhinosinusitis |
01(2.22) |
01(1.61) |
|
Adenoid Hyperytrophy |
01(2.22) |
01(1.61) |
|
Nasolabial cyst |
01(2.22) |
01(1.61) |
|
Non specific |
02(4.44) |
02(3.22) |
|
Total |
45(100) |
45(72.58) |
|
Neoplastic Benign |
Nasal Papilloma |
05(50) |
05(8.06) |
Haemangioma |
02(20) |
02(3.22) |
|
Angiofibroma |
01(10) |
01(1.61) |
|
Neurofibroma |
01(10) |
01(1.61) |
|
Schwannoma |
01(10) |
01(1.61) |
|
Total |
10(100) |
10(16.12) |
|
Neoplastic Malignant |
Sinonasal Carcinoma |
02(28.5) |
02(3.22) |
Naspharyngeal Carcinoma |
01(14.3) |
01(1.61) |
|
Teratocarcinosarcoma |
01(14.3) |
01(1.61) |
|
Basloid squamous carcinoma |
01(14.3) |
01(1.61) |
|
Adenoid cystic carcinoma |
01(14.3) |
01(1.61) |
|
Non Hodgkin’s Lymphoma |
01(14.3) |
01(1.61) |
|
Total |
07(100) |
07(11.29) |
|
|
Total No. of cases |
62(100) |
62(100) |